Xvivo Perfusion AB Mutual Funds

Health Care & Life Sciences » Biotechnology | Xvivo Perfusion AB

Xvivo Perfusion AB | Mutual Funds

Mutual Funds that own Xvivo Perfusion AB

Name

Shares Held

% Shares Out

Change In Shares

% of Assets

As of Date

Swedbank Robur Ny Teknik

1,630,000

6.22%

1.13%

07/31/2018

Catella Sverige Select

589,151

2.25%

-31,335

1.51%

08/31/2018

Tredje AP Fonden

406,408

1.55%

406,408

0.02%

06/30/2017

394,706

1.51%

-80,251

1.37%

08/31/2018

Echiquier Entrepreneurs

373,828

1.43%

373,828

1.43%

06/30/2017

LocalTapiola Growth Mutual Fund

276,079

1.05%

3.6%

05/31/2018

Länsförsäkringar Småbolagsfonden

238,983

0.91%

238,983

0.79%

07/31/2018

232,650

0.89%

-70,719

0.47%

08/31/2018

Strand Småbolagsfond

196,000

0.75%

7.16%

06/30/2017

Öhman Hjärt-Lungfond

132,839

0.51%

2.12%

12/31/2017

About Xvivo Perfusion AB

View Profile

Address	Mässans gata 10 Gothenburg VG 412 51 Sweden
Employees	-
Website	http://www.xvivoperfusion.com
Updated	07/08/2019
Xvivo Perfusion AB is a medical technology company which develops and markets solutions and systems for assessing the usability of organs, enabling the treatment of organs and maintaining organs in good condition outside the body pending transplantation. Its products include XPS, XPS Disposable Kit, Steen Solution, Organ Chamber, Lung Cannula Set, Perfadex, and Silicone Tubing Set. The company was founded on December 17, 1998 and is headquartered in Gothenburg, Sweden.